Skip to main content

Table 1 Population characteristics of the live birth and non-live birth groups

From: Pregnancy outcomes in women with infertility and coexisting endometriosis and adenomyosis after laparoscopic surgery: a long-term retrospective follow-up study

 

Group A

Group B

p value

Women who had a successful delivery(n = 97)

Women who did not have a successful delivery(n = 79)

Age (years)

32.52 ± 3.20

33.53 ± 3.95

0.046*

BMI (kg/m2)

21.74 ± 2.78

20.51 ± 4.72

0.033*

Type of Infertility n (%)

  

NS

 Primary infertility

60 (61.86%)

52 (65.82%)

 

 Secondary infertility

37 (38.14%)

27 (34.18%)

 

Gravida

0 (0–5)

0 (0–5)

NS

Parity

0 (0–1)

0 (0–2)

NS

Abortion history

19 (19.59%)

23 (29.11%)

NS

Previous ART

21 (21.65%)

14 (17.72%)

NS

Duration of infertility (years)

3 (1–8)

2 (1–11)

NS

Length of period (day)

5.88 ± 1.86

6.22 ± 2.04

NS

Menstrual cycle (day)

28.94 ± 6.17

28.94 ± 9.35

NS

Duration of dysmenorrhea (years)

5.33 ± 5.77

6.30 ± 6.29

NS

Dysmenorrhea (VAS)

4.22 ± 3.59

4.58 ± 3.49

NS

Anemia

13 (13.40%)

20 (25.32%)

0.044*

CA125(U/ml)

80.67 ± 92.47

109.57 ± 98.48

NS

FSH (IU/l)

7.12 ± 2.21

8.43 ± 2.81

0.005*

E2(pg/ml)

53.69 ± 41.14

48.88 ± 21.85

NS

Mean uterus diameter (cm)

4.91 ± 0.79

5.42 ± 1.20

0.001*

Mean cyst diameter (cm)

2.63 ± 3.43

4.38 ± 4.00

0.002*

  1. Note: Data are presented as mean ± SD, median (interquartile range) or n (%); NS, not significant; BMI, body mass index; ART assisted reproductive technology; VAS, visual analog scale; CA125, cancer antigen 125; FSH, follicle stimulating hormone; E2, estrogen
  2. *p < 0.05